|
|
|
Allergy Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for
Allergy.
Please click "Search" to find Allergy clinical trials and medical research
studies or read below for information on Allergy diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 5 studies:
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 90 studies:
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-15213
Conditions: Cow Milk Allergy
Location: Pittsburgh, PA
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-22180
Conditions: Cow Milk Allergy
Location: Vienna, VA
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-23113
Conditions: Cow Milk Allergy
Location: Midlothian, VA
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-27710
Conditions: Cow Milk Allergy
Location: Durham, NC
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-30281
Conditions: Cow Milk Allergy
Location: Stockbridge, GA
- A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy - NCT00664768-92868
Conditions: Cow Milk Allergy
Location: Orange, CA
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy - NCT01084174-21287
Conditions: Peanut Hypersensitivity - Food Hypersensitivity - Immediate Hypersensitivity
Location: Baltimore, MD
- An Interventional Study of Milk Allergy and Tolerance in Children - NCT00778258-10029
Conditions: Food Hypersensitivity - Milk Hypersensitivity
Location: New York, NY
- Comparison of CL Wear Between Two Allergy Drops - NCT00489398-91702
Conditions: Allergic Conjunctivitis
Location: Azusa, CA
- Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders - NCT00267501-45229
Conditions: Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease - Food Allergy
Location: Cincinnati, OH
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma - NCT00286416-92037
Conditions: Asthma - Allergic Rhinitis
Location: La Jolla, CA
- Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms - NCT01007253-60637
Conditions: Seasonal Allergic Rhinitis
Location: Chicago, IL
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Nashville, TN
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-10016
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: New York, NY
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-10032
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: New York, NY
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-33136
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Miami, FL
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-48109
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Ann Arbor, MI
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-55404
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Minneapolis, MN
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-90027
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Los Angeles, CA
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-91010
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Duarte, CA
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-94143
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: San Francisco, CA
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-94304
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Palo Alto, CA
- Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) - NCT00928200-98105
Conditions: Relapsed Acute Lymphoblastic Leukemia - Allergy to PEG e.Coli Asparaginase - Allergy to Native e.Coli Asparaginase
Location: Seattle, WA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-07601
Conditions: Leukemia
Location: Hackensack, NJ
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-10016
Conditions: Leukemia
Location: New York, NY
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-11040
Conditions: Leukemia
Location: New Hyde Park, NY
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-15213
Conditions: Leukemia
Location: Pittsburgh, PA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-19104
Conditions: Leukemia
Location: Philadelphia, PA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-19134
Conditions: Leukemia
Location: Philadelphia, PA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-20010
Conditions: Leukemia
Location: Washington, DC
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-21231
Conditions: Leukemia
Location: Baltimore, MD
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-22042
Conditions: Leukemia
Location: Falls Church, VA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-27157
Conditions: Leukemia
Location: Winston-Salem, NC
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-27599
Conditions: Leukemia
Location: Chapel Hill, NC
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-30322
Conditions: Leukemia
Location: Atlanta, GA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-32207
Conditions: Leukemia
Location: Jacksonville, FL
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-33701
Conditions: Leukemia
Location: Saint Petersburg, FL
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-35294
Conditions: Leukemia
Location: Birmingham, AL
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-37232
Conditions: Leukemia
Location: Nashville, TN
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-40232
Conditions: Leukemia
Location: Louisville, KY
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-43205
Conditions: Leukemia
Location: Columbus, OH
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-44106
Conditions: Leukemia
Location: Cleveland, OH
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-44195
Conditions: Leukemia
Location: Cleveland, OH
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-45229
Conditions: Leukemia
Location: Cincinnati, OH
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-46202
Conditions: Leukemia
Location: Indianapolis, IN
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-49007
Conditions: Leukemia
Location: Kalamazoo, MI
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-55404
Conditions: Leukemia
Location: Minneapolis, MN
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-55455
Conditions: Leukemia
Location: Minneapolis, MN
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-60453
Conditions: Leukemia
Location: Oak Lawn, IL
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-60614
Conditions: Leukemia
Location: Chicago, IL
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-63110
Conditions: Leukemia
Location: St. Louis, MO
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-64108
Conditions: Leukemia
Location: Kansas City, MO
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-73104
Conditions: Leukemia
Location: Oklahoma City, OK
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-75390
Conditions: Leukemia
Location: Dallas, TX
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-76104
Conditions: Leukemia
Location: Fort Worth, TX
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-80045
Conditions: Leukemia
Location: Aurora, CO
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-84113
Conditions: Leukemia
Location: Salt Lake City, UT
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-85016
Conditions: Leukemia
Location: Phoenix, AZ
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-87131
Conditions: Leukemia
Location: Albuquerque, NM
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-90027A
Conditions: Leukemia
Location: Downey, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-90027B
Conditions: Leukemia
Location: Los Angeles, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-90801
Conditions: Leukemia
Location: Long Beach, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-92123
Conditions: Leukemia
Location: San Diego, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-93638
Conditions: Leukemia
Location: Madera, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-94115
Conditions: Leukemia
Location: San Francisco, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-94305
Conditions: Leukemia
Location: Stanford, CA
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia - NCT00537030-98105
Conditions: Leukemia
Location: Seattle, WA
- Evaluating for Contact Allergies in Patients With Chronic Urticaria - NCT00868036-02111
Conditions: Urticaria - Patch Testing - Dermatitis - Allergy - Contact Sensitization
Location: Boston, MA
- Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract - NCT00927329-27599
Conditions: Dermatophagoides Farinae Allergy - Asthma - Healthy
Location: Chapel Hill, NC
- Food Allergy - Tubes - Adenoids (FATA) Trial - NCT00736112-65212
Conditions: Otitis Media With Effusion - Food Hypersensitivity
Location: Columbia, MO
- In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics - NCT00836368-27599
Conditions: Allergic - Asthmatic - Allergy - Asthma
Location: Chapel Hill, NC
- Mucosal Immunotherapy for Peanut Allergy in Young Children - NCT00932828-27710
Conditions: Food Hypersensitivity
Location: Durham, NC
- Nickel Allergy With Septal Closure Devices - NCT01068366-84132
Conditions: Atrial Septal Defect - Patent Foramen Ovale - Nickel Allergic Syndrome
Location: Salt Lake City, UT
- Omalizumab in the Treatment of Peanut Allergy - NCT00949078-21287
Conditions: Food Allergy - Peanut Allergy
Location: Baltimore, MD
- Oral Immunotherapy (OIT) for Peanut Allergy - NCT00815035-27710
Conditions: Peanut Hypersensitivity
Location: Durham, NC
- Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults - NCT00850668-10029
Conditions: Food Hypersensitivity - Hypersensitivity - Immediate Hypersensitivity - Peanut Hypersensitivity
Location: New York, NY
- Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults - NCT00850668-21205
Conditions: Food Hypersensitivity - Hypersensitivity - Immediate Hypersensitivity - Peanut Hypersensitivity
Location: Baltimore, MD
- Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy - NCT00932282-27710
Conditions: Peanut Hypersensitivity
Location: Durham, NC
- Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections - NCT00405899-15212
Conditions: Allergy - Seasonal Allergic Rhinitis - Perennial Allergic Rhinitis
Location: Pittsburgh, PA
- Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation - NCT00852943-20892
Conditions: Piebaldism - Idiopathic Anaphylaxis - Allergy - Chronic Urticara - Angioedema
Location: Bethesda, MD
- Study of Dust Mite Inhalation in Humans - NCT00448851-27599
Conditions: Mild Asthma - Allergy
Location: Chapel Hill, NC
- Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms - NCT00891436-60612
Conditions: Allergic Conjunctivitis to Tree Pollen or Grass Pollen
Location: Chicago, IL
- Study to Identify Non-Invasive Markers of Gastrointestinal Allergy - NCT00272818-02115
Conditions: Esophagitis - Colitis
Location: Boston, MA
- Sublingual Cockroach Safety Study (SCSS) - NCT00434421-21287
Conditions: Allergy - Asthma
Location: Baltimore, MD
- The Effect of Xolair (Omalizumab) on Allergy Blood Cells - NCT00657891-68131
Conditions: Asthma
Location: Omaha, NE
- The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge - NCT01003301-21224A
Conditions: Cat Allergy
Location: Baltimore, MD
- The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge - NCT01003301-21224B
Conditions: Cat Allergy
Location: Baltimore, MD
- Trichuris Suis Ova in Peanut Allergy - NCT01070498-02215
Conditions: Peanut Allergy
Location: Boston, MA
- Xolair Treatment for Milk Allergic Children - NCT00968110-02115
Conditions: Milk Allergy
Location: Boston, MA
- Xolair Treatment for Milk Allergic Children - NCT00968110-94305
Conditions: Milk Allergy
Location: Stanford, CA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|